These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10779024)

  • 1. Ten-day schedule oral etoposide therapy in advanced childhood malignancies.
    Schiavetti A; Varrasso G; Maurizi P; Cappelli C; Clerico A; Properzi E; Castello MA
    J Pediatr Hematol Oncol; 2000; 22(2):119-24. PubMed ID: 10779024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral etoposide for recurrent/progressive sarcomas of childhood.
    Kebudi R; Görgün O; Ayan I
    Pediatr Blood Cancer; 2004 Apr; 42(4):320-4. PubMed ID: 14966827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of recurrent medulloblastoma to low-dose oral etoposide.
    Ashley DM; Meier L; Kerby T; Zalduondo FM; Friedman HS; Gajjar A; Kun L; Duffner PK; Smith S; Longee D
    J Clin Oncol; 1996 Jun; 14(6):1922-7. PubMed ID: 8656261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of 21 day schedule oral etoposide in children. New Agents Group of the United Kingdom Children's Cancer Study Group (UKCCSG).
    Davidson A; Gowing R; Lowis S; Newell D; Lewis I; Dicks-Mireaux C; Pinkerton CR
    Eur J Cancer; 1997 Oct; 33(11):1816-22. PubMed ID: 9470839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral etoposide in relapsed or refractory Ewing sarcoma: a monoinstitutional experience in children and adolescents.
    Podda MG; Luksch R; Puma N; Gandola L; Morosi C; Terenziani M; Ferrari A; Casanova M; Spreafico F; Meazza C; Catania S; Schiavello E; Biassoni V; Chiaravalli S; Massimino M
    Tumori; 2016; 102(1):84-8. PubMed ID: 26797935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic oral VP-16 for recurrent medulloblastoma.
    Chamberlain MC; Kormanik PA
    Pediatr Neurol; 1997 Oct; 17(3):230-4. PubMed ID: 9390699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors.
    Needle MN; Molloy PT; Geyer JR; Herman-Liu A; Belasco JB; Goldwein JW; Sutton L; Phillips PC
    Med Pediatr Oncol; 1997 Jul; 29(1):28-32. PubMed ID: 9142202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide.
    Chamberlain MC
    Pediatr Neurol; 2001 Feb; 24(2):117-21. PubMed ID: 11275460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance chemotherapy with daily oral etoposide following salvage therapy in patients with germ cell tumors.
    Cooper MA; Einhorn LH
    J Clin Oncol; 1995 May; 13(5):1167-9. PubMed ID: 7738621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
    Korones DN; Smith A; Foreman N; Bouffet E
    Pediatr Blood Cancer; 2006 Jul; 47(1):37-41. PubMed ID: 16047359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of oral etoposide in children with refractory solid tumors.
    Mathew P; Ribeiro RC; Sonnichsen D; Relling M; Pratt C; Mahmoud H; Bowman L; Meyer W; Avery L; Crist W
    J Clin Oncol; 1994 Jul; 12(7):1452-7. PubMed ID: 8021737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
    Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of oral etoposide for patients with advanced breast cancer.
    Atienza DM; Vogel CL; Trock B; Swain SM
    Cancer; 1995 Dec; 76(12):2485-90. PubMed ID: 8625074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with oral etoposide for childhood recurrent ependymomas.
    Sandri A; Massimino M; Mastrodicasa L; Sardi N; Bertin D; Basso ME; Todisco L; Paglino A; Perilongo G; Genitori L; Valentini L; Ricardi U; Gandola L; Giangaspero F; Madon E
    J Pediatr Hematol Oncol; 2005 Sep; 27(9):486-90. PubMed ID: 16189442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of etoposide, cyclophosphamide, and total body irradiation in allogeneic bone marrow transplantation for adult patients with hematological malignancies.
    Toubai T; Tanaka J; Mori A; Hashino S; Kobayashi S; Ota S; Miura Y; Kato N; Kahata K; Izumiyama K; Yonezumi M; Chiba K; Kondo T; Toyoshima N; Asaka M; Imamura M
    Clin Transplant; 2004 Oct; 18(5):552-7. PubMed ID: 15344959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 21-day schedule oral etoposide in children--a feasibility study.
    Davidson A; Lewis I; Pearson AD; Stevens MC; Pinkerton CR
    Eur J Cancer; 1993; 29A(16):2223-5. PubMed ID: 8110489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage chemotherapy for recurrent spinal cord ependymona.
    Chamberlain MC
    Cancer; 2002 Sep; 95(5):997-1002. PubMed ID: 12209682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG; Blessing JA; Van Le L; Waggoner S
    Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
    Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
    Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.
    Souhami RL; Spiro SG; Rudd RM; Ruiz de Elvira MC; James LE; Gower NH; Lamont A; Harper PG
    J Natl Cancer Inst; 1997 Apr; 89(8):577-80. PubMed ID: 9106647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.